| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.904 | 0.004 | 0.93 | Antioxidant | 0.93 0.003 CID_154699632 | CID_154699632 | |
| 0.896 | 0.003 | 0.896 | Free radical scavenger | 0.896 0.003 CID_154699632 | ||
| 0.892 | 0.001 | 0.892 | Cystathionine beta-synthase inhibitor | 0.881 0.001 CID_154699632 | ||
| 0.883 | 0.001 | 0.883 | Peroxidase inhibitor | 0.516 0.008 CID_154699632 | ||
| 0.882 | 0.004 | 0.891 | Caspase 9 stimulant | 0.891 0.003 CID_154699632 | CID_154699632 | |
| 0.871 | 0.004 | 0.871 | Aldehyde oxidase inhibitor | 0.306 0.065 CID_154699632 | ||
| 0.866 | 0.009 | 0.866 | Apoptosis agonist | 0.846 0.011 CID_154699632 | ||
| 0.825 | 0.004 | 0.825 | 12-Lipoxygenase inhibitor | |||
| 0.823 | 0.005 | 0.823 | 15-Lipoxygenase inhibitor | |||
| 0.793 | 0.001 | 0.793 | Creatine kinase inhibitor | 0.32 0.004 CID_154699632 | ||
| 0.761 | 0.007 | 0.761 | Aryl hydrocarbon receptor agonist | 0.25 0.079 CID_154699632 | ||
| 0.74 | 0.002 | 0.74 | GABA C receptor rho-3 antagonist | 0.314 0.107 CID_154699632 | ||
| 0.734 | 0.003 | 0.734 | Interleukin 4 antagonist | 0.403 0.005 CID_154699632 | ||
| 0.753 | 0.025 | 0.945 | Alpha-glucosidase inhibitor | 0.945 0.005 CID_154699632 | CID_154699632 | |
| 0.716 | 0.004 | 0.866 | Histamine release inhibitor | 0.866 0.003 CID_154699632 | CID_154699632 | |
| 0.712 | 0.005 | 0.712 | Amyloid beta aggregation inhibitor | 0.556 0.01 CID_154699632 | ||
| 0.698 | 0.004 | 0.698 | Breast cancer-resistant protein inhibitor | 0.137 0.029 CID_154699632 | ||
| 0.698 | 0.003 | 0.698 | NOS3 expression enhancer | 0.69 0.004 CID_154699632 | ||
| 0.697 | 0.004 | 0.961 | Monophenol monooxygenase inhibitor | 0.961 0.002 CID_154699632 | CID_154699632 | |
| 0.692 | 0.003 | 0.9 | Xanthine oxidase inhibitor | 0.9 0.002 CID_154699632 | CID_154699632 | |
| 0.694 | 0.005 | 0.694 | Caspase 3 stimulant | 0.597 0.01 CID_154699632 | ||
| 0.715 | 0.028 | 0.865 | Antiinflammatory | 0.865 0.008 CID_154699632 | CID_154699632 | |
| 0.666 | 0.004 | 0.666 | MAO A inhibitor | |||
| 0.664 | 0.003 | 0.673 | NADPH oxidase inhibitor | 0.673 0.003 CID_154699632 | CID_154699632 | |
| 0.663 | 0.006 | 0.663 | Lipoxygenase inhibitor | |||
| 0.674 | 0.024 | 0.88 | Transcription factor NF kappa B inhibitor | 0.88 0.008 CID_154699632 | CID_154699632 | |
| 0.651 | 0.002 | 0.651 | Carbonic anhydrase III inhibitor | 0.426 0.004 CID_154699632 | ||
| 0.642 | 0.005 | 0.642 | MAO inhibitor | |||
| 0.633 | 0.002 | 0.633 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.177 0.012 CID_154699632 | ||
| 0.627 | 0.007 | 0.673 | Apoptosis antagonist | 0.673 0.005 CID_154699632 | CID_154699632 | |
| 0.625 | 0.008 | 0.73 | 5 Hydroxytryptamine release inhibitor | 0.73 0.004 CID_154699632 | CID_154699632 | |
| 0.616 | 0.007 | 0.664 | Hypoxia-inducible factor 1 alpha inhibitor | 0.664 0.005 CID_154699632 | CID_154699632 | |
| 0.608 | 0.005 | 0.608 | P-glycoprotein inhibitor | 0.378 0.018 CID_154699632 | ||
| 0.604 | 0.004 | 0.822 | Amylase inhibitor | 0.822 0.002 CID_154699632 | CID_154699632 | |
| 0.595 | 0.003 | 0.595 | Carbonic anhydrase VI inhibitor | 0.34 0.005 CID_154699632 | ||
| 0.586 | 0.005 | 0.586 | Topoisomerase II inhibitor | 0.564 0.005 CID_154699632 | ||
| 0.59 | 0.01 | 0.727 | Nitric oxide antagonist | 0.727 0.005 CID_154699632 | CID_154699632 | |
| 0.576 | 0.009 | 0.799 | Hypoglycemic | 0.799 0.004 CID_154699632 | CID_154699632 | |
| 0.549 | 0.004 | 0.563 | Lipid peroxidase inhibitor | 0.563 0.004 CID_154699632 | CID_154699632 | |
| 0.543 | 0.004 | 0.543 | Topoisomerase II alpha inhibitor | 0.466 0.004 CID_154699632 | ||
| 0.538 | 0.004 | 0.538 | Estrogen receptor beta antagonist | 0.126 0.026 CID_154699632 | ||
| 0.539 | 0.006 | 0.539 | Pyruvate kinase inhibitor | 0.292 0.05 CID_154699632 | ||
| 0.541 | 0.01 | 0.541 | Superoxide dismutase inhibitor | |||
| 0.539 | 0.009 | 0.563 | Vasodilator | 0.563 0.008 CID_154699632 | CID_154699632 | |
| 0.524 | 0.009 | 0.524 | RNA-directed DNA polymerase inhibitor | 0.457 0.013 CID_154699632 | ||
| 0.514 | 0.003 | 0.704 | Carbonic anhydrase XIII inhibitor | 0.704 0.003 CID_154699632 | CID_154699632 | |
| 0.514 | 0.006 | 0.758 | Melanin inhibitor | 0.758 0.003 CID_154699632 | CID_154699632 | |
| 0.51 | 0.005 | 0.51 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.538 | 0.034 | 0.538 | Prostaglandin dehydrogenase inhibitor | |||
| 0.509 | 0.006 | 0.509 | Dual specificity phosphatase inhibitor | 0.129 0.122 CID_154699632 | ||
| 0.505 | 0.002 | 0.505 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.323 0.003 CID_154699632 | ||
| 0.5 | 0.004 | 0.5 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.381 0.009 CID_154699632 | ||
| 0.501 | 0.005 | 0.501 | Chelator | 0.238 0.018 CID_154699632 | ||
| 0.495 | 0.004 | 0.495 | Estrogen antagonist | 0.177 0.016 CID_154699632 | ||
| 0.498 | 0.007 | 0.498 | Dual specificity phosphatase 3 inhibitor | |||
| 0.486 | 0.009 | 0.486 | Transcription factor STAT inhibitor | 0.21 0.125 CID_154699632 | ||
| 0.484 | 0.008 | 0.696 | Hepatoprotectant | 0.696 0.004 CID_154699632 | CID_154699632 | |
| 0.504 | 0.039 | 0.748 | Antibacterial | 0.748 0.006 CID_154699632 | CID_154699632 | |
| 0.464 | 0.005 | 0.464 | Protein-tyrosine phosphatase inhibitor | 0.321 0.015 CID_154699632 | ||
| 0.46 | 0.005 | 0.46 | Acetylcholinesterase inhibitor | 0.202 0.032 CID_154699632 | ||
| 0.458 | 0.004 | 0.458 | Histone deacetylase stimulant | 0.29 0.004 CID_154699632 | ||
| 0.458 | 0.004 | 0.458 | Histone deacetylase SIRT1 stimulant | 0.29 0.004 CID_154699632 | ||
| 0.465 | 0.021 | 0.83 | Vasodilator, coronary | 0.83 0.003 CID_154699632 | CID_154699632 | |
| 0.458 | 0.018 | 0.634 | Tumour necrosis factor alpha release inhibitor | 0.634 0.006 CID_154699632 | CID_154699632 | |
| 0.444 | 0.006 | 0.444 | MAO B inhibitor | |||
| 0.442 | 0.004 | 0.442 | Telomerase inhibitor | 0.087 0.04 CID_154699632 | ||
| 0.461 | 0.029 | 0.692 | Spasmolytic | 0.692 0.006 CID_154699632 | CID_154699632 | |
| 0.449 | 0.021 | 0.655 | Antiamyloidogenic | 0.655 0.005 CID_154699632 | CID_154699632 | |
| 0.426 | 0.004 | 0.426 | Aldose reductase inhibitor | 0.351 0.004 CID_154699632 | ||
| 0.425 | 0.004 | 0.425 | M18 aspartyl aminopeptidase inhibitor | 0.101 0.09 CID_154699632 | ||
| 0.423 | 0.003 | 0.508 | Nitric-oxide synthase stimulant | 0.508 0.002 CID_154699632 | CID_154699632 | |
| 0.447 | 0.028 | 0.447 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.421 | 0.007 | 0.519 | Protein kinase stimulant | 0.519 0.004 CID_154699632 | CID_154699632 | |
| 0.412 | 0.002 | 0.412 | Xanthine dehydrogenase inhibitor | 0.198 0.004 CID_154699632 | ||
| 0.43 | 0.022 | 0.599 | DNA damaging | 0.599 0.008 CID_154699632 | CID_154699632 | |
| 0.444 | 0.037 | 0.444 | Streptokinase A inhibitor | |||
| 0.41 | 0.004 | 0.41 | HIV-1 integrase (3'-Processing) inhibitor | 0.172 0.012 CID_154699632 | ||
| 0.407 | 0.003 | 0.407 | GABA C receptor rho-2 antagonist | 0.134 0.097 CID_154699632 | ||
| 0.406 | 0.004 | 0.437 | Alcohol dehydrogenase inhibitor | 0.437 0.004 CID_154699632 | CID_154699632 | |
| 0.396 | 0.005 | 0.596 | Alkaline phosphatase inhibitor | 0.596 0.003 CID_154699632 | CID_154699632 | |
| 0.455 | 0.065 | 0.841 | Cyclophilin D inhibitor | 0.841 0.005 CID_154699632 | CID_154699632 | |
| 0.392 | 0.005 | 0.392 | 5-Lipoxygenase inhibitor | |||
| 0.401 | 0.022 | 0.819 | Angiogenesis stimulant | 0.819 0.004 CID_154699632 | CID_154699632 | |
| 0.382 | 0.006 | 0.422 | Aldehyde dehydrogenase inhibitor | 0.422 0.005 CID_154699632 | CID_154699632 | |
| 0.38 | 0.004 | 0.38 | HIV-1 integrase (Strand Transfer) inhibitor | 0.165 0.012 CID_154699632 | ||
| 0.383 | 0.01 | 0.477 | DNA methyltransferase I inhibitor | 0.477 0.005 CID_154699632 | CID_154699632 | |
| 0.373 | 0.003 | 0.373 | Multidrug resistance-associated protein 1 inhibitor | 0.282 0.004 CID_154699632 | ||
| 0.386 | 0.017 | 0.386 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.368 | 0.004 | 0.368 | Estrogen agonist | 0.242 0.006 CID_154699632 | ||
| 0.369 | 0.005 | 0.369 | Carbonic anhydrase XV inhibitor | 0.103 0.063 CID_154699632 | ||
| 0.362 | 0.004 | 0.362 | Histidine decarboxylase inhibitor | 0.077 0.045 CID_154699632 | ||
| 0.362 | 0.007 | 0.362 | Protein-tyrosine phosphatase 1B inhibitor | 0.272 0.013 CID_154699632 | ||
| 0.361 | 0.008 | 0.361 | Heat shock protein 90 alpha antagonist | |||
| 0.379 | 0.029 | 0.379 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.367 | 0.017 | 0.607 | Non-steroidal antiinflammatory agent | 0.607 0.004 CID_154699632 | CID_154699632 | |
| 0.359 | 0.013 | 0.359 | Cholinergic | 0.13 0.096 CID_154699632 | ||
| 0.352 | 0.007 | 0.352 | Protein kinase (CK2) alpha inhibitor | |||
| 0.361 | 0.017 | 0.494 | Platelet adhesion inhibitor | 0.494 0.005 CID_154699632 | CID_154699632 | |
| 0.337 | 0.005 | 0.337 | Uric acid excretion stimulant | 0.276 0.005 CID_154699632 | ||
| 0.349 | 0.017 | 0.462 | DNA methylase inhibitor | 0.462 0.007 CID_154699632 | CID_154699632 | |
| 0.336 | 0.004 | 0.336 | Estrogen receptor alpha antagonist | |||
| 0.332 | 0.007 | 0.332 | Heat shock protein 90 antagonist | 0.133 0.093 CID_154699632 | ||
| 0.357 | 0.038 | 0.357 | Interleukin antagonist | 0.233 0.068 CID_154699632 | ||
| 0.328 | 0.017 | 0.328 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.311 | 0.002 | 0.311 | D-Ala-D-Ala ligase inhibitor | 0.091 0.042 CID_154699632 | ||
| 0.32 | 0.013 | 0.32 | Amyloid beta precursor protein antagonist | |||
| 0.309 | 0.005 | 0.309 | Protein kinase C zeta inhibitor | |||
| 0.375 | 0.074 | 0.543 | Immunosuppressant | 0.543 0.022 CID_154699632 | CID_154699632 | |
| 0.319 | 0.02 | 0.319 | Mcl-1 antagonist | |||
| 0.299 | 0.003 | 0.299 | Fatty acid synthase inhibitor | 0.187 0.004 CID_154699632 | ||
| 0.336 | 0.041 | 0.336 | Dyrk kinase inhibitor | |||
| 0.319 | 0.025 | 0.319 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.298 | 0.006 | 0.751 | Beta glucuronidase inhibitor | 0.751 0.002 CID_154699632 | CID_154699632 | |
| 0.31 | 0.018 | 0.31 | Tubulin antagonist | |||
| 0.294 | 0.005 | 0.294 | Aromatase inhibitor | |||
| 0.292 | 0.003 | 0.292 | Carbonic anhydrase VII inhibitor | 0.239 0.004 CID_154699632 | ||
| 0.292 | 0.004 | 0.292 | Macrophage migration inhibitory factor inhibitor | |||
| 0.35 | 0.064 | 0.773 | Antithrombotic | 0.773 0.005 CID_154699632 | CID_154699632 | |
| 0.296 | 0.011 | 0.296 | Succinate dehydrogenase inhibitor | 0.146 0.12 CID_154699632 | ||
| 0.302 | 0.017 | 0.302 | Bone formation stimulant | 0.189 0.039 CID_154699632 | ||
| 0.401 | 0.119 | 0.401 | DNA polymerase beta inhibitor | |||
| 0.283 | 0.004 | 0.283 | Estrogen receptor beta agonist | 0.158 0.007 CID_154699632 | ||
| 0.28 | 0.005 | 0.557 | AMP-activated protein kinase stimulant | 0.557 0.003 CID_154699632 | CID_154699632 | |
| 0.392 | 0.118 | 0.392 | DNA directed DNA polymerase inhibitor | |||
| 0.277 | 0.004 | 0.277 | Cyclin B3 inhibitor | |||
| 0.274 | 0.004 | 0.274 | Heat shock protein 70 antagonist | 0.265 0.004 CID_154699632 | ||
| 0.274 | 0.003 | 0.274 | DOPA decarboxylase inhibitor | 0.118 0.048 CID_154699632 | ||
| 0.275 | 0.009 | 0.275 | Protein kinase (CK2) inhibitor | |||
| 0.281 | 0.015 | 0.345 | Insulin secretagoues | 0.345 0.009 CID_154699632 | CID_154699632 | |
| 0.276 | 0.012 | 0.276 | Butyrylcholinesterase inhibitor | |||
| 0.267 | 0.004 | 0.267 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.311 | 0.048 | 0.311 | Transcription factor STAT3 inhibitor | |||
| 0.275 | 0.013 | 0.369 | Topoisomerase I inhibitor | 0.369 0.007 CID_154699632 | CID_154699632 | |
| 0.264 | 0.004 | 0.264 | Myeloperoxidase inhibitor | |||
| 0.26 | 0.004 | 0.26 | Transcription factor STAT6 inhibitor | |||
| 0.258 | 0.004 | 0.258 | GABA C receptor rho-1 antagonist | |||
| 0.273 | 0.019 | 0.611 | Hemostatic | 0.611 0.003 CID_154699632 | CID_154699632 | |
| 0.257 | 0.005 | 0.388 | Photosensitizer | 0.388 0.003 CID_154699632 | CID_154699632 | |
| 0.255 | 0.006 | 0.255 | GABA C receptor antagonist | |||
| 0.271 | 0.024 | 0.271 | Tumour necrosis factor antagonist | |||
| 0.25 | 0.004 | 0.25 | CDC25A inhibitor | 0.105 0.025 CID_154699632 | ||
| 0.249 | 0.006 | 0.249 | CF transmembrane conductance regulator agonist | 0.193 0.025 CID_154699632 | ||
| 0.27 | 0.028 | 0.295 | Neurotrophic factor enhancer | 0.295 0.019 CID_154699632 | CID_154699632 | |
| 0.246 | 0.005 | 0.246 | Electron transport complex I inhibitor | 0.1 0.084 CID_154699632 | ||
| 0.256 | 0.022 | 0.256 | Cytokine production inhibitor | |||
| 0.251 | 0.021 | 0.251 | Cyclooxygenase 1 inhibitor | 0.182 0.042 CID_154699632 | ||
| 0.227 | 0.004 | 0.227 | Estrogen receptor alpha agonist | 0.052 0.017 CID_154699632 | ||
| 0.225 | 0.007 | 0.225 | Papain-like protease (SARS coronavirus) inhibitor | 0.133 0.055 CID_154699632 | ||
| 0.251 | 0.034 | 0.251 | Insulin sensitizer | 0.238 0.042 CID_154699632 | ||
| 0.22 | 0.005 | 0.22 | Carbonic anhydrase V inhibitor | |||
| 0.217 | 0.004 | 0.217 | Aryl hydrocarbon receptor antagonist | |||
| 0.22 | 0.013 | 0.587 | Cyclooxygenase 3 inhibitor | 0.587 0.002 CID_154699632 | CID_154699632 | |
| 0.211 | 0.007 | 0.211 | T cell inhibitor | 0.192 0.008 CID_154699632 | ||
| 0.231 | 0.031 | 0.231 | Cyclooxygenase inhibitor | 0.227 0.032 CID_154699632 | ||
| 0.328 | 0.134 | 0.328 | Calcium channel L-type activator | |||
| 0.196 | 0.005 | 0.196 | Carbonic anhydrase VA inhibitor | |||
| 0.269 | 0.08 | 0.269 | Insulysin inhibitor | |||
| 0.192 | 0.006 | 0.192 | Interleukin 5 antagonist | 0.154 0.01 CID_154699632 | ||
| 0.202 | 0.021 | 0.344 | Antineoplastic antibiotic | 0.344 0.007 CID_154699632 | CID_154699632 | |
| 0.193 | 0.013 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.184 | 0.005 | 0.184 | CDC25B inhibitor | 0.064 0.044 CID_154699632 | ||
| 0.182 | 0.005 | 0.182 | HIV-1 integrase inhibitor | 0.099 0.025 CID_154699632 | ||
| 0.188 | 0.012 | 0.188 | Urease inhibitor | |||
| 0.193 | 0.027 | 0.193 | Toll-Like receptor 2 antagonist | |||
| 0.181 | 0.016 | 0.181 | Androgen antagonist | |||
| 0.197 | 0.032 | 0.213 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 CID_154699632 | CID_154699632 | |
| 0.192 | 0.029 | 0.397 | Alkylator | 0.397 0.008 CID_154699632 | CID_154699632 | |
| 0.168 | 0.007 | 0.168 | Thioredoxin reductase inhibitor | 0.087 0.046 CID_154699632 | ||
| 0.18 | 0.019 | 0.542 | Mediator release inhibitor | 0.542 0.004 CID_154699632 | CID_154699632 | |
| 0.173 | 0.012 | 0.188 | Thioredoxin inhibitor | 0.188 0.009 CID_154699632 | CID_154699632 | |
| 0.193 | 0.033 | 0.197 | Cyclooxygenase 2 inhibitor | 0.197 0.032 CID_154699632 | CID_154699632 | |
| 0.249 | 0.089 | 0.249 | 5 Hydroxytryptamine release stimulant | 0.196 0.125 CID_154699632 | ||
| 0.268 | 0.112 | 0.268 | Thyroid hormone antagonist | |||
| 0.199 | 0.044 | 0.199 | Phospholipase C inhibitor | 0.174 0.068 CID_154699632 | ||
| 0.171 | 0.017 | 0.367 | DNA repair enzyme inhibitor | 0.367 0.004 CID_154699632 | CID_154699632 | |
| 0.25 | 0.096 | 0.594 | Immunostimulant | 0.594 0.017 CID_154699632 | CID_154699632 | |
| 0.195 | 0.043 | 0.37 | Interferon gamma antagonist | 0.37 0.012 CID_154699632 | CID_154699632 | |
| 0.16 | 0.013 | 0.16 | Keratolytic | |||
| 0.153 | 0.007 | 0.175 | Neuraminidase (influenza) inhibitor | 0.175 0.005 CID_154699632 | CID_154699632 | |
| 0.155 | 0.009 | 0.155 | Lipase inhibitor | 0.098 0.028 CID_154699632 | ||
| 0.149 | 0.005 | 0.149 | Protease activated receptor antagonist | |||
| 0.153 | 0.009 | 0.153 | Alpha tubulin antagonist | |||
| 0.149 | 0.006 | 0.149 | Neuraminidase inhibitor | 0.149 0.006 CID_154699632 | ||
| 0.152 | 0.012 | 0.276 | Interleukin 12 antagonist | 0.276 0.004 CID_154699632 | CID_154699632 | |
| 0.143 | 0.003 | 0.143 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.254 | 0.116 | 0.254 | Thyroid hormone beta antagonist | |||
| 0.139 | 0.003 | 0.139 | Dopamine D5 agonist | |||
| 0.185 | 0.049 | 0.185 | Arachidonic acid antagonist | |||
| 0.17 | 0.036 | 0.17 | Cholesterol synthesis inhibitor | 0.132 0.055 CID_154699632 | ||
| 0.181 | 0.048 | 0.338 | Hexokinase inhibitor | 0.338 0.007 CID_154699632 | CID_154699632 | |
| 0.175 | 0.043 | 0.281 | Alpha-N-acetylglucosaminidase inhibitor | 0.281 0.018 CID_154699632 | CID_154699632 | |
| 0.136 | 0.005 | 0.136 | Heat shock protein 90 beta antagonist | |||
| 0.134 | 0.004 | 0.134 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.134 | 0.01 | 0.134 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.13 | 0.007 | 0.13 | CD45 antagonist | |||
| 0.144 | 0.025 | 0.144 | Prolactin inhibitor | |||
| 0.16 | 0.042 | 0.16 | Farnesoid X receptor antagonist | |||
| 0.133 | 0.015 | 0.264 | Carbonic anhydrase XII inhibitor | 0.264 0.005 CID_154699632 | CID_154699632 | |
| 0.201 | 0.083 | 0.201 | Antimitotic | |||
| 0.128 | 0.013 | 0.128 | Alcohol oxidase inhibitor | |||
| 0.126 | 0.011 | 0.126 | Protein kinase C eta inhibitor | 0.06 0.034 CID_154699632 | ||
| 0.129 | 0.015 | 0.129 | Beta tubulin antagonist | |||
| 0.118 | 0.004 | 0.118 | GABA B receptor antagonist | |||
| 0.119 | 0.007 | 0.196 | Carbonic anhydrase XIV inhibitor | 0.196 0.004 CID_154699632 | CID_154699632 | |
| 0.116 | 0.005 | 0.116 | Glutamate (mGluR7) antagonist | |||
| 0.151 | 0.04 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.147 0.051 CID_154699632 | ||
| 0.138 | 0.03 | 0.138 | Sphingomyelinase inhibitor | 0.106 0.053 CID_154699632 | ||
| 0.135 | 0.027 | 0.135 | Anabolic | |||
| 0.137 | 0.029 | 0.189 | Toll-Like receptor 4 antagonist | 0.189 0.008 CID_154699632 | CID_154699632 | |
| 0.17 | 0.062 | 0.17 | Neurotensin receptor agonist | |||
| 0.14 | 0.033 | 0.317 | UDP-glucose 4-epimerase inhibitor | 0.317 0.009 CID_154699632 | CID_154699632 | |
| 0.152 | 0.045 | 0.152 | Antibacterial (Helicobacter pylori) | |||
| 0.241 | 0.134 | 0.241 | Vasodilator, peripheral | |||
| 0.193 | 0.087 | 0.193 | MAP kinase kinase 2 inhibitor | |||
| 0.151 | 0.046 | 0.151 | Proteasome inhibitor | |||
| 0.148 | 0.043 | 0.197 | DNA intercalator | 0.197 0.027 CID_154699632 | CID_154699632 | |
| 0.124 | 0.02 | 0.124 | Glutathione S-transferase inhibitor | |||
| 0.17 | 0.068 | 0.17 | Death-associated protein kinase 2 inhibitor | |||
| 0.107 | 0.005 | 0.107 | Transcription factor RelA inhibitor | |||
| 0.109 | 0.009 | 0.109 | Cyclin B1 inhibitor | |||
| 0.123 | 0.023 | 0.123 | Ornithine decarboxylase inhibitor | 0.101 0.044 CID_154699632 | ||
| 0.108 | 0.008 | 0.108 | Cyclin B2 inhibitor | |||
| 0.113 | 0.014 | 0.113 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.123 | 0.025 | 0.123 | CYP2A6 inhibitor | |||
| 0.195 | 0.098 | 0.383 | Cyclic AMP phosphodiesterase inhibitor | 0.383 0.019 CID_154699632 | CID_154699632 | |
| 0.1 | 0.004 | 0.1 | Protein kinase (CK2) beta inhibitor | |||
| 0.137 | 0.041 | 0.158 | Mucolytic | 0.158 0.028 CID_154699632 | CID_154699632 | |
| 0.208 | 0.112 | 0.375 | DNA synthesis inhibitor | 0.375 0.025 CID_154699632 | CID_154699632 | |
| 0.123 | 0.029 | 0.123 | ABCA1 expression enhancer | |||
| 0.098 | 0.004 | 0.182 | Arginase inhibitor | 0.182 0.002 CID_154699632 | CID_154699632 | |
| 0.108 | 0.014 | 0.108 | Carbonic anhydrase VB inhibitor | |||
| 0.135 | 0.043 | 0.135 | TRPA1 agonist | 0.098 0.09 CID_154699632 | ||
| 0.159 | 0.066 | 0.159 | Phospholipase A2 inhibitor | 0.122 0.114 CID_154699632 | ||
| 0.107 | 0.014 | 0.111 | Maillard reaction inhibitor | 0.111 0.013 CID_154699632 | CID_154699632 | |
| 0.115 | 0.023 | 0.115 | Glutamate decarboxylase inhibitor | |||
| 0.096 | 0.005 | 0.096 | Catechol O-methyltransferase inhibitor | |||
| 0.119 | 0.029 | 0.119 | Phosphodiesterase 4D inhibitor | |||
| 0.133 | 0.043 | 0.448 | Expectorant | 0.448 0.004 CID_154699632 | CID_154699632 | |
| 0.15 | 0.062 | 0.15 | Adenylate cyclase stimulant | |||
| 0.105 | 0.02 | 0.105 | Leukotriene antagonist | 0.085 0.029 CID_154699632 | ||
| 0.177 | 0.092 | 0.177 | I kappa B kinase epsilon inhibitor | |||
| 0.123 | 0.039 | 0.123 | Potassium channel (Ca-activated) activator | |||
| 0.127 | 0.045 | 0.127 | GABA C receptor agonist | |||
| 0.093 | 0.011 | 0.093 | Cyclin B inhibitor | |||
| 0.121 | 0.041 | 0.121 | Pim-1 kinase inhibitor | |||
| 0.082 | 0.003 | 0.082 | Estrogen-related receptor beta antagonist | 0.034 0.018 CID_154699632 | ||
| 0.126 | 0.048 | 0.126 | Nav1.5 sodium channel blocker | |||
| 0.104 | 0.028 | 0.136 | Na+ K+ transporting ATPase inhibitor | 0.136 0.009 CID_154699632 | CID_154699632 | |
| 0.087 | 0.012 | 0.087 | Sphingosine kinase inhibitor | |||
| 0.151 | 0.077 | 0.39 | Diuretic | 0.39 0.014 CID_154699632 | CID_154699632 | |
| 0.132 | 0.06 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_154699632 | CID_154699632 | |
| 0.108 | 0.036 | 0.194 | NADH dehydrogenase inhibitor | 0.194 0.011 CID_154699632 | CID_154699632 | |
| 0.088 | 0.02 | 0.088 | CDK4/cyclin D1 inhibitor | |||
| 0.141 | 0.072 | 0.141 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.115 | 0.046 | 0.115 | CDK2/cyclin A inhibitor | |||
| 0.096 | 0.029 | 0.096 | Adenosine A3 receptor antagonist | |||
| 0.099 | 0.034 | 0.099 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.101 | 0.036 | 0.101 | Porphobilinogen synthase inhibitor | |||
| 0.105 | 0.043 | 0.188 | Triose-phosphate isomerase inhibitor | 0.188 0.012 CID_154699632 | CID_154699632 | |
| 0.072 | 0.011 | 0.072 | CXC chemokine 1 receptor antagonist | |||
| 0.094 | 0.033 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.091 | 0.031 | 0.091 | Leukotriene synthesis inhibitor | |||
| 0.073 | 0.014 | 0.073 | Potassium channel Kv1.3 blocker | |||
| 0.087 | 0.029 | 0.087 | MAP kinase kinase 7 inhibitor | |||
| 0.163 | 0.105 | 0.198 | Psychostimulant | 0.198 0.081 CID_154699632 | CID_154699632 | |
| 0.059 | 0.005 | 0.059 | ATP citrate lysase inhibitor | |||
| 0.094 | 0.041 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.068 | 0.016 | 0.068 | Leukotriene C antagonist | |||
| 0.07 | 0.02 | 0.109 | Leukotriene B4 antagonist | 0.109 0.009 CID_154699632 | CID_154699632 | |
| 0.063 | 0.013 | 0.063 | DNA-dependent protein kinase inhibitor | |||
| 0.07 | 0.021 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.063 | 0.018 | 0.063 | Adenosine deaminase inhibitor | 0.05 0.03 CID_154699632 | ||
| 0.128 | 0.084 | 0.128 | Neurotrophic factor | |||
| 0.064 | 0.02 | 0.118 | Glucose-6-phosphate translocase inhibitor | 0.118 0.004 CID_154699632 | CID_154699632 | |
| 0.062 | 0.019 | 0.062 | Squalene epoxidase inhibitor | |||
| 0.078 | 0.036 | 0.078 | Potassium channel large-conductance Ca-activated activator | |||
| 0.136 | 0.095 | 0.136 | MAP kinase kinase 4 inhibitor | |||
| 0.058 | 0.02 | 0.058 | Cholesterol esterase inhibitor | |||
| 0.045 | 0.008 | 0.045 | Estrone sulfatase inhibitor | |||
| 0.056 | 0.021 | 0.056 | Carbonic anhydrase IV inhibitor | |||
| 0.069 | 0.034 | 0.069 | Phosphatidylinositol kinase inhibitor | |||
| 0.068 | 0.033 | 0.068 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.051 | 0.016 | 0.051 | DNA gyrase subunit A inhibitor | 0.04 0.037 CID_154699632 | ||
| 0.074 | 0.04 | 0.074 | Protein kinase C beta inhibitor | |||
| 0.076 | 0.043 | 0.162 | Phosphofructokinase-1 inhibitor | 0.162 0.016 CID_154699632 | CID_154699632 | |
| 0.057 | 0.024 | 0.057 | Topoisomerase II beta inhibitor | 0.054 0.027 CID_154699632 | ||
| 0.208 | 0.177 | 0.208 | Sodium/bile acid cotransporter inhibitor | |||
| 0.073 | 0.043 | 0.073 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.06 | 0.03 | 0.06 | Dihydroorotate oxidase inhibitor | |||
| 0.051 | 0.022 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_154699632 | CID_154699632 | |
| 0.069 | 0.04 | 0.091 | Carbonic anhydrase inhibitor | 0.091 0.03 CID_154699632 | CID_154699632 | |
| 0.064 | 0.038 | 0.064 | Purinergic P2X1 antagonist | |||
| 0.081 | 0.056 | 0.081 | Opioid kappa receptor antagonist | |||
| 0.068 | 0.043 | 0.068 | Glutamate (mGluR6) antagonist | |||
| 0.076 | 0.052 | 0.076 | GABA aminotransferase inhibitor | 0.073 0.057 CID_154699632 | ||
| 0.044 | 0.02 | 0.044 | Retinoic acid alpha receptor agonist | |||
| 0.141 | 0.118 | 0.281 | ATPase inhibitor | 0.281 0.008 CID_154699632 | CID_154699632 | |
| 0.227 | 0.204 | 0.227 | Transcription factor inhibitor | |||
| 0.055 | 0.033 | 0.055 | mTOR inhibitor | |||
| 0.074 | 0.053 | 0.103 | Phosphodiesterase VI inhibitor | 0.103 0.018 CID_154699632 | CID_154699632 | |
| 0.03 | 0.009 | 0.03 | Dopamine D1 agonist | 0.026 0.012 CID_154699632 | ||
| 0.096 | 0.075 | 0.096 | Adenylate kinase inhibitor | |||
| 0.044 | 0.024 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.05 | 0.03 | 0.067 | Glucose-6-phosphate isomerase inhibitor | 0.067 0.014 CID_154699632 | CID_154699632 | |
| 0.051 | 0.032 | 0.051 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | |||
| 0.047 | 0.029 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.091 | 0.073 | 0.133 | Phosphodiesterase 6D inhibitor | 0.133 0.016 CID_154699632 | CID_154699632 | |
| 0.148 | 0.131 | 0.148 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.063 | 0.047 | 0.063 | Beta 3 adrenoreceptor antagonist | |||
| 0.083 | 0.067 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.09 | 0.074 | 0.09 | Bile acid receptor antagonist | |||
| 0.133 | 0.118 | 0.22 | Interleukin 6 antagonist | 0.22 0.031 CID_154699632 | CID_154699632 | |
| 0.089 | 0.075 | 0.089 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.06 | 0.046 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.043 CID_154699632 | CID_154699632 | |
| 0.025 | 0.012 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 CID_154699632 | CID_154699632 | |
| 0.063 | 0.05 | 0.063 | Dopamine agonist | |||
| 0.045 | 0.033 | 0.045 | Purinergic P2X4 antagonist | |||
| 0.137 | 0.125 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.032 | 0.022 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.15 | 0.139 | 0.15 | Histone acetyltransferase inhibitor | |||
| 0.057 | 0.047 | 0.057 | Cyclin D1 inhibitor | |||
| 0.108 | 0.099 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.033 | 0.024 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.023 CID_154699632 | ||
| 0.04 | 0.031 | 0.04 | Sphingosine kinase 1 inhibitor | |||
| 0.059 | 0.05 | 0.059 | Heme oxygenase stimulant | |||
| 0.068 | 0.06 | 0.068 | Glutamate dehydrogenase inhibitor | |||
| 0.016 | 0.009 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.115 | 0.108 | 0.292 | Cell wall synthesis inhibitor | 0.292 0.01 CID_154699632 | CID_154699632 | |
| 0.054 | 0.048 | 0.054 | CDK4/cyclin D inhibitor | |||
| 0.058 | 0.052 | 0.058 | Dopamine D1 antagonist | |||
| 0.023 | 0.017 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.019 | 0.014 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_154699632 | CID_154699632 | |
| 0.054 | 0.05 | 0.054 | Opioid delta receptor antagonist | |||
| 0.022 | 0.019 | 0.073 | Protein 30S ribosomal subunit inhibitor | 0.073 0.004 CID_154699632 | CID_154699632 | |
| 0.02 | 0.018 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.076 | 0.074 | 0.076 | Opioid antagonist | |||
| 0.18 | 0.179 | 0.18 | Gastrin inhibitor | |||
| 0.169 | 0.168 | 0.169 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.05 | 0.049 | 0.05 | Adenosine A1 receptor antagonist | |||
| 0.023 | 0.025 | 0.1 | Sodium/glucose cotransporter 2 inhibitor | 0.1 0.003 CID_154699632 | CID_154699632 | |
| 0.132 | 0.135 | 0.134 | Anesthetic general | 0.134 0.132 CID_154699632 | CID_154699632 | |
| 0.185 | 0.188 | 0.226 | Angiogenesis inhibitor | 0.226 0.142 CID_154699632 | CID_154699632 | |
| 0.146 | 0.15 | 0.367 | Platelet antagonist | 0.367 0.034 CID_154699632 | CID_154699632 | |
| 0.021 | 0.029 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 CID_154699632 | CID_154699632 | |
| 0.021 | 0.033 | 0.083 | Sodium/glucose cotransporter inhibitor | 0.083 0.003 CID_154699632 | CID_154699632 | |
| 0.013 | 0.025 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_154699632 | CID_154699632 | |
| 0.036 | 0.055 | 0.062 | Carbonic anhydrase IX inhibitor | 0.062 0.036 CID_154699632 | CID_154699632 | |
| 0.091 | 0.109 | 0.121 | Microtubule formation inhibitor | 0.121 0.06 CID_154699632 | CID_154699632 | |
| 0.064 | 0.085 | 0.085 | Interferon agonist | 0.085 0.045 CID_154699632 | CID_154699632 | |
| 0.073 | 0.097 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.067 CID_154699632 | CID_154699632 | |
| 0.048 | 0.075 | 0.08 | Nitric oxide donor | 0.08 0.022 CID_154699632 | CID_154699632 | |
| 0.084 | 0.115 | 0.115 | Beta amyloid protein antagonist | 0.115 0.072 CID_154699632 | CID_154699632 | |
| 0.048 | 0.095 | 0.061 | Interferon inducer | 0.061 0.051 CID_154699632 | CID_154699632 | |
| 0.038 | 0.088 | 0.106 | Heparanase inhibitor | 0.106 0.004 CID_154699632 | CID_154699632 | |
| 0.035 | 0.094 | 0.046 | Cytokine production stimulant | 0.046 0.041 CID_154699632 | CID_154699632 | |
| 0.08 | 0.142 | 0.135 | Ribosomal protein S6 kinase inhibitor | 0.135 0.077 CID_154699632 | CID_154699632 | |
| 0.153 | 0.218 | 0.353 | Cholesterol antagonist | 0.353 0.063 CID_154699632 | CID_154699632 | |
| 0.023 | 0.092 | 0.079 | Antibiotic Aminoglycoside-like | 0.079 0.004 CID_154699632 | CID_154699632 | |
| 0.083 | 0.154 | 0.362 | Thrombolytic | 0.362 0.015 CID_154699632 | CID_154699632 | |
| 0.055 | 0.128 | 0.162 | Falcipain 2 inhibitor | 0.162 0.024 CID_154699632 | CID_154699632 | |
| 0.056 | 0.132 | 0.164 | Falcipain inhibitor | 0.164 0.025 CID_154699632 | CID_154699632 | |
| 0.02 | 0.099 | 0.042 | Phosphorylase inhibitor | 0.042 0.035 CID_154699632 | CID_154699632 | |
| 0.029 | 0.115 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 CID_154699632 | CID_154699632 | |
| 0.048 | 0.138 | 0.079 | Glycine receptor antagonist | 0.079 0.058 CID_154699632 | CID_154699632 | |
| 0.042 | 0.135 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 CID_154699632 | CID_154699632 | |
| 0.02 | 0.12 | 0.058 | Mannosidase inhibitor | 0.058 0.018 CID_154699632 | CID_154699632 | |
| 0.135 | 0.243 | 0.391 | Peptidyltransferase inhibitor | 0.391 0.008 CID_154699632 | CID_154699632 | |
| 0.011 | 0.134 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 CID_154699632 | CID_154699632 | |
| 0.022 | 0.156 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_154699632 | CID_154699632 | |
| 0.085 | 0.237 | 0.245 | Interleukin agonist | 0.245 0.082 CID_154699632 | CID_154699632 | |
| 0.034 | 0.196 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 CID_154699632 | CID_154699632 | |
| 0.03 | 0.195 | 0.052 | Factor III inhibitor | 0.052 0.031 CID_154699632 | CID_154699632 | |
| 0.02 | 0.187 | 0.357 | Selectin antagonist | 0.357 0.004 CID_154699632 | CID_154699632 | |
| 0.079 | 0.26 | 0.308 | Hypolipemic | 0.308 0.046 CID_154699632 | CID_154699632 | |
| 0.025 | 0.223 | 0.091 | DNA gyrase inhibitor | 0.091 0.021 CID_154699632 | CID_154699632 | |
| 0.016 | 0.223 | 0.104 | Protein 50S ribosomal subunit inhibitor | 0.104 0.012 CID_154699632 | CID_154699632 | |
| 0.097 | 0.31 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.03 CID_154699632 | CID_154699632 | |
| 0.117 | 0.404 | 0.4 | Interleukin 2 agonist | 0.4 0.027 CID_154699632 | CID_154699632 | |
| 0.024 | 0.36 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 CID_154699632 | CID_154699632 | |
| 0.069 | 0.484 | 0.463 | Immunomodulator | 0.463 0.029 CID_154699632 | CID_154699632 | |
| 0.033 | 0.51 | 0.119 | Transcription factor NF kappa B stimulant | 0.119 0.026 CID_154699632 | CID_154699632 | |
| 0.013 | 0.629 | 0.2 | Anticoagulant | 0.2 0.053 CID_154699632 | CID_154699632 | |
| 0.009 | 0.654 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_154699632 | CID_154699632 | |
| 0.012 | 0.742 | 0.216 | Cell adhesion inhibitor | 0.216 0.021 CID_154699632 | CID_154699632 | |
| 0.011 | 0.833 | 0.052 | Factor IXa inhibitor | 0.052 0.035 CID_154699632 | CID_154699632 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |